Neuren Pharmaceuticals Ltd Long-term Investment Intensity
Neuren Pharmaceuticals Ltd long-term investment intensity. Neuren Pharmaceuticals Ltd (NEU) has a Long-term Investment Intensity of 7.7% as of December 2017. Long-term investments of AU$1.37 Million represent 7.7% of total assets of AU$17.94 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read NEU liabilities breakdown for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Neuren Pharmaceuticals Ltd (2017–2017)
Long-term investment intensity of Neuren Pharmaceuticals Ltd from 2017 to 2017. This chart shows how Neuren Pharmaceuticals Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2017 to 2017. As of December 2017, the intensity stands at 7.7%, reflecting long-term investments of AU$1.37 Million against total assets of AU$17.94 Million AUD.
Neuren Pharmaceuticals Ltd Long-term Investment Intensity by Year (2017–2017)
Neuren Pharmaceuticals Ltd long-term investment intensity by year from 2017 to 2017. The table below presents the year-by-year Long-term Investment Intensity for Neuren Pharmaceuticals Ltd from 2017 to 2017, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see NEU total asset value.
| Year | LT Investment Intensity | LT Investments (AUD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2017 | 7.7% | AU$1.37 Million | AU$17.94 Million | — |